amylin analog vs glp 1 Identification and utility exploration of a highly potent and long-acting bullfrog GLP-1 analogue in GLP-1 and combination therapy Amycretin — a novel obesity

Eligible individuals include: Those with a body mass index (BMI) of 35 or higher, or Those with a BMI of 30 or higher who also have at least one qualifying medical condition, including: High blood pressure Prediabetes A previous heart attack or stroke Blocked arteries Chronic kidney disease Heart failure The pilot marks the first time Medicare has covered medications prescribed specifically for weight loss

These meals changed everything

To date, preclinical HFpEF models have primarily utilized single perturbations to replicate the human HFpEF phenotype

Flashback Friday: How to Reduce Your TMAO Levels Should we be concerned about high-choline plant foods, such as broccoli, producing the same toxic TMAO that results from eating high-choline animal foods, such as eggs

Turk, B., Turk, D

Inhibition of caspase-3 activity and activation by protein glutathionylation